Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00401284 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness
A Phase 2 study of Sleep Initiation and Maintenance Disorders, sponsored by Evotec Neurosciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 135
- Enrollment target
- 20
- Study locations
NCT00401284 is a Phase 2 study of Sleep Initiation and Maintenance Disorders that has completed, run by Evotec Neurosciences. The registered enrollment target is 135 participants, below the 283-participant average among 19 other Sleep Initiation and Maintenance Disorders trials with a reported enrollment target (52% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT00401284, a Phase 2 study of Sleep Initiation and Maintenance Disorders, has completed, sponsored by Evotec Neurosciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 135 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating elderly patients diagnosed with primary insomnia who also have moderate daytime sleepiness.
Conditions Studied
Interventions
- DRUG EVT 201
Study Locations (20)
Florida
- Miami Research Associates - Miami
- OmniTrials, 11181 Health Park Blvd, Suite 3040 - Naples
- Broward Research Group - Pembroke Pines
- Clinical Research Group of St Petersburg Inc., 2525 Pasadena Ave So, Suite S - St. Petersburg
Arizona
- PsyPharma Clinical Research Inc. - Phoenix
- PsyPharma Clinical Research, Inc. - Tucson
California
- Pacific Sleep Medicine Services Inc - Los Angeles
- Pacific Sleep Medicine Services - San Diego
Georgia
- The Sleep Disorders Center of Georgia, Peachtree Dunwoody Medical Center, 5505 Peachtree Dunwoody Road, Suite 548 - Atlanta
- Sleep Disorders Center of Georgia - Gainesville - Gainesville
Ohio
- Community Research - Cincinnati
- Tri-State Sleep Disorders Center, 1275 East Kemper Road - Cincinnati
Kansas
- Vince and Assocaites Clinical Research - Overland Park
Kentucky
- Community Research - Crestview Hills
Mississippi
- Center for Sleep Medicine, 101 Courtney Circle - Hattiesburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00401284
The ClinicalTrials.gov registry entry for NCT00401284 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 283-participant average among 19 other Sleep Initiation and Maintenance Disorders trials with a reported enrollment target (52% lower). The listed sponsor is Evotec Neurosciences, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Initiation and Maintenance Disorders appearing as the primary indexed condition, and to 1 intervention - of which EVT 201 is the first listed.
NCT00401284 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT00401284 about?
NCT00401284 is a clinical study titled "Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness". The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating elderly patients diagnosed with primary insomnia who also have moderate daytime sleepiness.
What is the current status of trial NCT00401284?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 135 participants. The study started on 2006-11. Estimated completion is 2007-07.
What conditions does trial NCT00401284 study?
This clinical trial studies the following conditions: Sleep Initiation and Maintenance Disorders.
What interventions are being tested in trial NCT00401284?
The interventions under investigation include: EVT 201 (DRUG).
Who is sponsoring clinical trial NCT00401284?
This trial is sponsored by Evotec Neurosciences, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00401284 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Initiation and Maintenance Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia
COMPLETED · Phase 2
-
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
COMPLETED · Phase 2
-
Efficacy Study of LY2422347 to Treat Insomnia
COMPLETED · Phase 2
-
Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.
COMPLETED · Phase 2
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.